Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. [electronic resource]
- Journal of the American Academy of Dermatology Apr 2019
- 1029-1072 p. digital
Publication Type: Journal Article; Practice Guideline; Review
1097-6787
10.1016/j.jaad.2018.11.057 doi
Adalimumab--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Biological Products--therapeutic use Biosimilar Pharmaceuticals--therapeutic use Certolizumab Pegol--therapeutic use Dermatologic Agents--therapeutic use Drug Therapy, Combination Etanercept--therapeutic use Evidence-Based Medicine Humans Infliximab--therapeutic use Piperidines--therapeutic use Psoriasis--drug therapy Pyrimidines--therapeutic use Pyrroles--therapeutic use Ustekinumab--therapeutic use